Investor Relations Overview

Webcast ImageWebcast
CryoLife, Inc to Acquire Hemosphere, Inc - Conference Call (Replay)
05/15/12 at 11:00 a.m. ET
CryoLife, Inc to Acquire Hemosphere, Inc

Corporate Profile

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and Canada. CryoLife's CryoValve® SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft® technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. CryoLife's CryoPatch...More >>

Fortune Small Business congratulates CryoLife for making the 2009 hot list of the fastest-growing firms in America!
More>>
Today's Quote
CRY (Common Stock)
ExchangeNYSE (US Dollar)
Price$4.77
Change (%) Stock is Down 0.16 (3.25%)
Volume97,292
05/16/12 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Documents
Annual Meeting Materials
2009 Annual Report - Adobe PDF2011 Annual Report
Proxy Statement and Notice of Annual Meeting - Adobe PDFProxy Statement and Notice of Annual Meeting
Proxy Card - Adobe PDFProxy Card
Recent NewsMore >>
DateTitle
05/16/12CryoLife Completes Acquisition of Hemosphere
05/15/12CryoLife to Acquire Hemosphere
04/26/12CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Upcoming EventsMore >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.